Concepedia

Ching-Fei Li

CL

Statistics

Publications

4

Citations

802

H-Index

4

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Tianjin Medical University General Hospital

China Medical University

Genomics Research Center, Academia Sinica

Ching-Fei Li is an author at The University of Texas MD Anderson Cancer Center specializing in tumor progression, oncology, and medicine.

Publications per year

2017–2022

4

Publications

4

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Ri‐Yao Yang, Linlin Sun, Ching-Fei Li et al. · Nature Communications · 2021 · 605 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Snail-induced claudin-11 prompts collective migration for tumour progression

Ching-Fei Li, Jia-Yang Chen, Yang-Hui Ho et al. · Nature Cell Biology · 2019 · 147 citations

Medicine, Cancer Biology, Cell Biology +14

Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death

Ri‐Yao Yang, Linlin Sun, Ching-Fei Li et al. · Journal of Biological Chemistry · 2022 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

Promoter hypermethylation of <i>LGALS4</i> correlates with poor prognosis in patients with urothelial carcinoma

Meei‐Maan Wu, Ching-Fei Li, Li-Fang Lin et al. · Oncotarget · 2017 · 14 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–4 of 4